The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

MILPITAS, Calif. , Oct. 01, 2025 (GLOBE NEWSWIRE) -- Elixir Medical, a developer of disruptive technologies to treat cardiovascular disease, today announced key milestone and full market release of ...

Gift Article 10 Remaining As a subscriber, you have 10 articles to gift each month. Gifting allows recipients to access the article for free. Abbott Laboratories is launching a new clinical trial to ...

Calcified femoropopliteal arterial disease remains a major challenge in endovascular therapy. Vessel preparation technologies have emerged to improve ...

PARIS--(BUSINESS WIRE)--Elixir Medical, a developer of transformative technologies to treat cardiovascular and peripheral disease, today announced that the PINNACLE I study evaluating the safety and ...

MILAN--(BUSINESS WIRE)--Quanta System SpA (El.En. Group – Mid Cap Star Segment of the Italian Stock Exchange – ELN.MI) announces today a very important milestone in developing a new laser technology, ...

Please provide your email address to receive an email when new articles are posted on . In the Disrupt BTK pilot study, intravascular lithotripsy successfully treated calcified and stenotic ...

Bolt Medical announced the intravascular ultrasound (IVUS) results of 22 patients enrolled in the RESTORE FIH (First in Human) Coronary feasibility clinical trial using the company's Bolt IVL™ ...

Please provide your email address to receive an email when new articles are posted on . Shockwave Medical announced its intravascular lithotripsy system received premarket approval from the FDA for ...

LithiX™ HC-IVL is a novel lithotripsy system designed to facilitate treatment of heart disease exacerbated by the presence of calcium within coronary artery plaques MILPITAS, Calif., Nov. 06, 2025 ...